Encompass Health Corporation (NYSE: EHC) reported Q4 EPS of $0.88, $0.04 better than the analyst estimate of $0.84. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.12 billion.

GUIDANCE:

Encompass Health Corporation sees FY2023 EPS of $2.87-$3.16, versus the consensus of $3.25. Encompass Health Corporation sees FY2023 revenue of $4.68-4.76 billion, versus the consensus of $4.67 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.